Get started
JSW Energy Ltd Analysis: Head and Shoulders Formation and Potent Description : The Head and Shoulders pattern on JSW Energy's daily chart suggests a potential reversal to the downside. The key support level at 601.55 is being tested, and if it breaks, we could see a further decline towards 520.60 . The pattern's key components are marked: Left Shoulder : Formation before the rise. Head : The peak followed by a consolidation. Right Shoulder : Another attempt to rise but failing, indicating the reversal. A clean breakdown below the neckline at 601.55 would signal a stronger bearish move. Target Level : 520.60 Stay ahead of market movements with technical insights . Learn technical setups with @PriceActionTrader_yt.
NSE:JSWENERGYShort
by pas_infinity
THE TUBE OSCILLATOR - LIVE ON STAGE THE TUBE OSCILLATOR is the world's ONLY oscillator which has been validated as a scientific research work by the University of Heidelberg and published as a scientific work (there is enough evidence about THE TUBE OSCILLATOR on the web). Thank you for following me. I ask the users who don't follow me to follow me so that we can benefit from it together. I wish you all a good start to trading. I plan to offer the OSCILLATOR as a SCRIPT very soon, exclusively for TradingView users. Sufficient number of followers is necessary! The TUBE OSCILLATOR script is limited to a limited number of users!!!
NASDAQ:MSFT
by BlackLaceOne
The Rapid Growing Malaysia Health Care SectorMalaysia’s healthcare landscape is entering a transformative phase, underpinned by a robust allocation of RM45.3 billion in the 2025 national budget—a 10% increase compared to 2024. This commitment, the second-largest budget allocation after education, underscores the government’s focus on addressing rising healthcare demands, including an ageing population, chronic diseases, and urban-rural healthcare gaps. The government’s strategic initiatives, including RM1.3 billion for hospital upgrades and RM300 million for dilapidated clinics in rural areas, highlight a push towards more efficient healthcare delivery. Fitch Solutions’ BMI predicts that Malaysia's healthcare expenditure will grow at an impressive compound annual growth rate (CAGR) of 8.7% from 2023 to 2028, outpacing previous estimates. This growth will be fuelled by increased demand for both public and private healthcare services, bolstered by initiatives such as outsourcing public patient care to 91 private hospitals and the gradual rollback of subsidies for higher-income individuals. The shift in subsidies is expected to drive affluent patients towards private healthcare, expanding opportunities for private healthcare providers. Private healthcare companies, especially those involved in preventive care and supplements, stand to benefit significantly from these trends. One notable player is Nasdaq-listed Agape ATP Corporation (ATPC), a leading healthcare supplement company in Malaysia. With Malaysia’s emphasis on chronic disease prevention and healthier lifestyles, Agape ATP is well-positioned to meet the rising demand for wellness products. The company’s established reputation and product range make it an attractive choice as the nation prioritises self-sufficiency in medical products and preventive healthcare. Moreover, the government’s New Industrial Master Plan 2030, aimed at strengthening domestic production of medical products, offers additional prospects for growth. By focusing on advanced diagnostic tools and in-vitro diagnostics, Malaysia is setting the stage for a more globally competitive healthcare ecosystem. As healthcare spending increases and demand for quality services rises, companies like Agape ATP are likely to see enhanced opportunities to expand and thrive. For investors, Malaysia’s growing healthcare sector and its well-aligned private players present a compelling case for long-term value.
NASDAQ:ATPCLong
by HASHInvests200
Mercari Stock Trend Analysis: Reversal Signals and Growth OpportIf you're an investor based in Japan, consider keeping an eye on Mercari's stock. It appears to be forming a bottom, with weekly candlestick charts showing increasing trading volume as the price approaches key support levels. While it may take considerable time to revisit its previous highs, the stock exhibits promising signals of a potential trend reversal. This could mark the end of its downtrend and the beginning of a sustainable upward trajectory.
TSE:4385Long
by MonTaDono
THE TUBE OSCILLATOR - REALTIME WORK FOR January 06, 2025THE TUBE OSCILLATOR is the world's ONLY oscillator which has been validated as a scientific research work by the University of Heidelberg and published as a scientific work (there is enough evidence about THE TUBE OSCILLATOR on the web). Thank you for following me. I ask the users who don't follow me to follow me so that we can benefit from it together. I wish you all a good start to trading. I plan to offer the OSCILLATOR as a SCRIPT very soon, exclusively for TradingView users. Sufficient number of followers is necessary! The TUBE OSCILLATOR script is limited to a limited number of users!!!
NASDAQ:MSFT
by BlackLaceOne
Outlook Therapeutics $2.24. Huge potential upside.Outlook Therapeutics are a bio drug company specialising in treating a progressive eyesight problem that affects millions of elderly people worldwide. The disease is called wet macular degeneration. Outlook have been given approval in Europe and the uk for their new treatment and plan to sell the treatment in these markets in the first half of 2025. Outlook’s application for FDA approval was postponed last December, they were asked to provide more information, the company says they are continuing the trial and plan to resubmit in the first quarter for FDA approval. If Outlook get approval, one post on the wires suggests that this is likely, the price will fly. There is only one other treatment currently available for this disease that affects 20 Million people in the USA.
NASDAQ:OTLKLong
by RIckAshby
ALANSCOTT BO & wait for retestThe stock provided a breakout and is currently encountering some supply at its all-time high. It would be wise to let it absorb this supply and wait for a retest before considering entry. For a successful SL hit, we should ideally see a strong 1week candle on our chart—it’s crucial to use that timeframe. Following the breakdown, the ideal exit point would be after a consecutive candle that breaks below the breakdown candle As always, remember to do your own research before making any investment decisions!
BSE:ALANSCOTTLong
by ShivNetha
Technical Analysis on Advent Technologies Holdings (ADN)The chart for ADN clearly illustrates its performance: a rapid surge at the end of 2020, followed by a consistent decline from 2021, leading to a 99% drop in value. After reaching its lows around $1.70, the stock entered a sideways consolidation phase that lasted several months. It then staged a strong recovery with a gap away and a breakout of the descending trendline. Currently, the stock is in a compression phase, forming a Triangle pattern, with converging highs and lows. Bullish Scenario In a bullish scenario, a breakout above the triangle is required, ideally accompanied by an increase in trading volumes. The Volume Profile indicates the absence of significant resistance levels that could hinder the upward movement. Bearish Scenario In a bearish scenario, the stock would need to break below the triangle. However, the Volume Profile highlights a high-volume node represented by the rectangle, which also contains the POC (Point of Control). Before a sustained decline can occur, the stock would need to breach this strong support zone.
NASDAQ:ADN
by Giovanni_Bandini
Titan Cement: Impressive its progress in 2024Titan Cement (TITC) Group, the Titan of the Athens Stock Exchange, which was the first stock I bought as an investor in 1987, ended 2024 with a shower of new historical highs in its share value. The group posted record sales in the nine-month period at 1.984 billion euros, up by +4.9% compared to the corresponding period last year. At the same time, it posted a strong increase of +14.6% in EBITDA profits, closing at 454.5 million euros, from 396.7 million euros in the nine-month period last year, while it also had a significant increase of +20.3%, to 237.8 million euros, from 197.6 million euros, in net profitability. In 2025, we will also have the listing of Titan America on the New York Stock Exchange, thus giving significant goodwill to the group, while the raising of several hundred million dollars will further lower the already “wonderful” net debt / EBITDA ratio, which at the end of last September was at 1.10x. From a diagrammatic point of view, the stock is moving within the strongly upward “S” channel governed by the two pivots of 2019. Here it is clearly visible that the stock has now taken an upward slope towards 44 euros, with a possible development of breaking the four-year channel with a move towards 48 to 50 euros.
ATHEX:TITCLong
by manthos
GEK Terna: Profitability will be beyond expectationsGEK Terna (GEKTERNA), the national champion in the infrastructure and concessions sector, will appear even stronger in 2025, with Attiki Odos and Egnatia Odos starting to fill its coffers. Of great interest is the analysis by Eurobank Equities, which predicts the group's revenues to increase from 2.96 billion euros in 2024 to 3.3 billion euros in 2025 and 3.6 billion euros in 2026, with its profitability, however, "breaking them". Specifically, EBITDA profits are expected to increase by +38%, from 452.4 million euros in 2024 to 623.8 million euros (!) in 2025 and to 692.5 million euros in 2026. euros in 2026. The concessions sector is expected to be the spearhead of the group for the coming years, an element that would easily lead the management to decide to list it on the Stock Exchange. A sector that is expected to bring operating profits of more than 480 to 500 million euros (!). In the long-term diagrammatic analysis, we have a strong upward channel “D”, which has governed the share price since January 2016. An 8-year formation that pushes the share higher and higher, breaking through the gates of 7.56 euros, 10.18 euros, 14.18 euros and is now approaching 20.25 euros, which will lead to 24.70 euros.
ATHEX:GEKTERNALong
by manthos
Cenergy Holdings:The incredible growth story extends beyond 2030In the case of Cenergy Holdings (CENER), words are unnecessary. The growth story of this group is incredible and extends beyond 2030. The comparison of this year's nine months with last year is characteristic, with the percentage figures having escaped, such as the +44% in EBITDA from 137 million euros to 196.8 million euros and the more than doubling in pre-tax profits of 123 million euros from 60.1 million euros and after-tax profits of 100.26 million euros from 47.16 million euros, reminiscent more of an IT company than a giant industrial group. So in this group that is going to reach 400 million euros in operating profits in the next two years, before even putting the new Hellenic Cables factory in the US into full operation, the long-term chart of the stock shows a strong upward trend. The stock, taking prices within the “W” channel, has broken resistances such as those at 3.465 euros, 7.20 euros and around 10.18 euros, in order to continue towards 12.80 euros. The extension of this pattern gives prices even above 14 euros.
ATHEX:CENERLong
by manthos